Hermann Leying

1.0k total citations
19 papers, 755 citations indexed

About

Hermann Leying is a scholar working on Molecular Medicine, Pharmacology and Endocrinology. According to data from OpenAlex, Hermann Leying has authored 19 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Medicine, 7 papers in Pharmacology and 6 papers in Endocrinology. Recurrent topics in Hermann Leying's work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Escherichia coli research studies (5 papers). Hermann Leying is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Escherichia coli research studies (5 papers). Hermann Leying collaborates with scholars based in Germany and Switzerland. Hermann Leying's co-authors include W. Opferkuch, Sebastian Suerbaum, Gabriele Geis, W. Cullmann, Rainer Haas, Hein‐Peter Kroll, Helge Karch, U. Mai, David A. Stahl and Wolfgang R. Dick and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Molecular Microbiology.

In The Last Decade

Hermann Leying

19 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hermann Leying Germany 14 282 212 197 191 167 19 755
Jin-Yong Jeong South Korea 13 406 1.4× 149 0.7× 57 0.3× 211 1.1× 153 0.9× 21 909
Gabriele Geis Germany 13 322 1.1× 65 0.3× 79 0.4× 141 0.7× 158 0.9× 18 618
H. W. B. Engel Netherlands 15 430 1.5× 67 0.3× 53 0.3× 167 0.9× 116 0.7× 27 1.1k
Cara L. Cooke United States 14 266 0.9× 45 0.2× 60 0.3× 218 1.1× 221 1.3× 14 652
H. Pruul Australia 15 52 0.2× 207 1.0× 62 0.3× 138 0.7× 133 0.8× 27 713
Tessa M. Andermann United States 12 137 0.5× 86 0.4× 72 0.4× 318 1.7× 87 0.5× 29 630
A Gorea Israel 11 68 0.2× 196 0.9× 49 0.2× 327 1.7× 90 0.5× 26 752
D.G. Groothuis Netherlands 15 57 0.2× 52 0.2× 203 1.0× 315 1.6× 165 1.0× 30 945
Yasuo Mizuguchi Japan 19 77 0.3× 141 0.7× 310 1.6× 276 1.4× 266 1.6× 49 939
Chin-Fu Lin Taiwan 15 60 0.2× 159 0.8× 113 0.6× 115 0.6× 45 0.3× 28 611

Countries citing papers authored by Hermann Leying

Since Specialization
Citations

This map shows the geographic impact of Hermann Leying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann Leying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann Leying more than expected).

Fields of papers citing papers by Hermann Leying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermann Leying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann Leying. The network helps show where Hermann Leying may publish in the future.

Co-authorship network of co-authors of Hermann Leying

This figure shows the co-authorship network connecting the top 25 collaborators of Hermann Leying. A scholar is included among the top collaborators of Hermann Leying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermann Leying. Hermann Leying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Leying, Hermann, et al.. (2009). Hepatitis B virus (HBV) genotype determination by the COBAS® AmpliPrep/COBAS® TaqMan® HBV Test, v2.0 in serum and plasma matrices. Journal of Clinical Virology. 45(3). 232–236. 13 indexed citations
2.
Leying, Hermann, et al.. (2006). Fully automated quantitation of Hepatitis B virus (HBV) DNA in human plasma by the COBAS® AmpliPrep/COBAS® TaqMan® System☆, ☆☆. Journal of Clinical Virology. 35(4). 373–380. 54 indexed citations
3.
Strobel, Eric J., et al.. (1995). Biotin in vitro translation, nonradioactive detection of cell-free synthesized proteins.. PubMed. 18(5). 900–4, 906. 7 indexed citations
4.
Suerbaum, Sebastian, Susanne Friedrich, Hermann Leying, & W. Opferkuch. (1994). Expression of capsular polysaccacharide determines serum resistance in Escherichia coli k92. Zentralblatt für Bakteriologie. 281(2). 146–157. 8 indexed citations
5.
Geis, Gabriele, et al.. (1993). Ultrastructure and biochemical studies of the flagellar sheath of Helicobacter pylori. Journal of Medical Microbiology. 38(5). 371–377. 93 indexed citations
6.
Leying, Hermann, Sebastian Suerbaum, Gabriele Geis, & Rainer Haas. (1992). Cloning and genetic characterization of a Hellcobacter pylori flagellin gene. Molecular Microbiology. 6(19). 2863–2874. 140 indexed citations
7.
Leying, Hermann, et al.. (1992). Lipopolysaccharide Alterations Responsible for Combined Quinolone and β-Lactam Resistance in <i>Pseudomonas aeruginosa</i>. Chemotherapy. 38(2). 82–91. 14 indexed citations
8.
Leying, Hermann, et al.. (1991). Imipenem Resistance in <i>Acinetobacter baumanii</i> Is Due to Altered Penicillin-Binding Proteins. Chemotherapy. 37(6). 405–412. 119 indexed citations
9.
Leying, Hermann, W. Cullmann, & Wolfgang R. Dick. (1991). Carbapenem Resistance in <i>Enterobacter aerogenes</i> is due to Lipopolysaccharide Alterations. Chemotherapy. 37(2). 106–113. 20 indexed citations
10.
Leying, Hermann, et al.. (1990). Role of the Outer Membrane for Quinolone Resistance in Enterobacteria. Chemotherapy. 36(1). 13–23. 14 indexed citations
11.
Suerbaum, Sebastian, Hermann Leying, Bernhard Meyer, & W. Opferkuch. (1990). Influence of beta-lactam antibiotics on serum resistance of K1-positive blood culture isolates of Escherichia coli. Antimicrobial Agents and Chemotherapy. 34(4). 628–631. 5 indexed citations
12.
Geis, Gabriele, Hermann Leying, Sebastian Suerbaum, & W. Opferkuch. (1990). Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori. Journal of Clinical Microbiology. 28(5). 930–932. 48 indexed citations
13.
Leying, Hermann, Sebastian Suerbaum, Hein‐Peter Kroll, David A. Stahl, & W. Opferkuch. (1990). The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Infection and Immunity. 58(1). 222–227. 60 indexed citations
14.
Geis, Gabriele, Hermann Leying, Sebastian Suerbaum, U. Mai, & W. Opferkuch. (1989). Ultrastructure and chemical analysis of Campylobacter pylori flagella. Journal of Clinical Microbiology. 27(3). 436–441. 74 indexed citations
15.
Suerbaum, Sebastian, et al.. (1987). Influence of beta-lactam antibiotics and ciprofloxacin on cell envelope of Escherichia coli. Antimicrobial Agents and Chemotherapy. 31(7). 1106–1110. 19 indexed citations
16.
Leying, Hermann, Sebastian Suerbaum, Hein‐Peter Kroll, Helge Karch, & W. Opferkuch. (1986). Influence of beta-lactam antibiotics and ciprofloxacin on composition and immunogenicity of Escherichia coli outer membrane. Antimicrobial Agents and Chemotherapy. 30(3). 475–480. 13 indexed citations
17.
Karch, Helge, Hermann Leying, Peter Goroncy‐Bermes, Hein‐Peter Kroll, & W. Opferkuch. (1985). Three-dimensional structure of fimbriae determines specificity of immune response. Infection and Immunity. 50(2). 517–522. 14 indexed citations
18.
Karch, Helge, et al.. (1985). Isolation and separation of physicochemically distinct fimbrial types expressed on a single culture of Escherichia coli O7:K1:H6. Infection and Immunity. 47(2). 549–554. 16 indexed citations
19.
Karch, Helge, Hermann Leying, & W. Opferkuch. (1984). Analysis of electrophoretically heterogeneous lipopolysaccharides ofEscherichia coliby immunoblotting. FEMS Microbiology Letters. 22(3). 193–196. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026